Novartis | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Amgen USD 2.31B 182M 2024-12
AstraZeneca USD 2.04B 731M 2024-12
Bausch Health Companies USD 318M 105M 2024-09
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 696M 507M 2024-12
Glaxosmithkline GBP 702M 513M 2024-12
Indivior 66M 226M 2025-03
J&J USD 13.63B 9.74B 2025-03
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pacira USD 24.7M 164.23M 2024-12
Perrigo USD 112.7M 37.4M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Prestige Brands USD 91.96M 7.62M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Sanofi EUR 861M 2.77B 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Zoetis USD 732M 142M 2024-12



Novartis L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.